http://www.businessspectator.com.au/bs.nsf/Article/Acclaim-Exploration-seeks-assurances-on-funding-sh-JVSYX?OpenDocument(.>_<)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%